Cancer research center hotline: complement depletion: use of human C3/cobra venom factor (CVF) chimeric proteins as therapeutic agents.
dc.contributor.author | Fritzinger, David C | |
dc.date.accessioned | 2016-10-25T22:41:59Z | |
dc.date.available | 2016-10-25T22:41:59Z | |
dc.date.issued | 2005-05 | |
dc.identifier.issn | 0017-8594 | |
dc.identifier.pubmed | 15989147 | |
dc.identifier.uri | http://hdl.handle.net/10524/53464 | |
dc.language.iso | eng | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Cobra Venoms/pharmacology | |
dc.subject.mesh | Complement Activation | |
dc.subject.mesh | Complement C3/physiology | |
dc.subject.mesh | Complement Inactivator Proteins/pharmacology | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Neoplasms/therapy | |
dc.subject.mesh | Recombinant Fusion Proteins/pharmacology | |
dc.title | Cancer research center hotline: complement depletion: use of human C3/cobra venom factor (CVF) chimeric proteins as therapeutic agents. | |
dc.type | Article | |
dc.type.dcmi | Text | |
prism.number | 5 | |
prism.pagerange | 133-4, 137 | |
prism.publicationname | Hawaii Medical Journal | |
prism.volume | 64 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- 2005-05p133-137.pdf
- Size:
- 321.66 KB
- Format:
- Adobe Portable Document Format